August 8, 2023
- November 19, 2020 - Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional). See NOFO PAR-21-059
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to inform applicants of the early termination of PAR-21-059 "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)". The remaining September 7, 2023 AIDS Application due date has been canceled. Effective immediately, this Notice of Funding Opportunity (NOFO) is expired. Changes to the NOFO are shown below.
Currently Reads:
Part 1. Overview Information
Key Dates
| AIDS Application Due Date(s) | May 4, 2021, September 7, 2021, May 7, 2022, September 7, 2022, May 7, 2023, September 7, 2023, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
| Expiration Date | September 8, 2023 |
Modified to Read:
Part 1. Overview Information
Key Dates
| AIDS Application Due Date(s) | May 4, 2021, September 7, 2021, May 7, 2022, September 7, 2022, May 7, 2023 by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date |
| Expiration Date | August 8, 2023 |
All other aspects of this NOFO remain unchanged.
Carol Taylor-Burds, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: [email protected]
and Human Services (HHS)
